+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Protein Chip Market by Technology, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5521539
  • Report
  • October 2021
  • Region: Global
  • 299 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Agilent Technologies
  • Arrayit Corporation
  • Bio-Rad laboratories
  • Danher Corporation
  • Illumina Inc
  • Merck KGGA
The global protein chip market was valued at $652.8 million in 2020, and is projected to reach $1,367.1 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.


Protein chips, also known as protein microarrays, are miniaturized and parallel assay systems that contain small amounts of purified proteins in a high-density format. They allow simultaneous determination of a great variety of analytes from small amounts of samples within a single experiment.

Protein microarray or chip technology is a process of immobilizing proteins on to a solid slide support and utilizing a miniaturized assay to demonstrate protein interactions that has been developed steadily in past years. It is a powerful methodology in a high-throughput format to analyze thousands of known proteins in a single experiment. Protein microarrays are indispensable tools for proteomic applications, multi-parameter clinical diagnostic tests, and many other fields. Protein chips are used for development of new assay detection of protein-binding properties (protein-protein interaction, protein-peptide interaction, protein-DNA interaction, protein-small molecule interaction, and protein-glycan interaction), profiling monoclonal antibody specificity, biomarker identification, and host-pathogen interactions.

Major factors that impact growth of the protein chip market include increase in global burden of cancer, which has significantly mounted over the past decade as protein chips can be used in detection of particular cancer protein for accurate cancer diagnosis and finalization of treatment therapy. In addition, biomarkers have the potential to improve early diagnosis rate of cancer. However, owing to the drawback of traditional biomarkers and diagnostic methods, they are not an ideal diagnostic tools in clinical practice. Therefore, new biomarkers and simple and efficient test methods such as a smaller sample and miniaturization and protein microarray technology do have great potential in cancer diagnosis. However, complexity of protein microarray (chip) during production and quantification is expected to impede growth of the protein chip market during the forecast period.

The market is expected to witness moderate growth during the forecast period, owing to technological advancements in protein chip and increase in private funding and government grants for R&D in protein chip.

The protein chip market is segmented on the basis of technology, application, end user, and region. By technology, it is divided into analytical microarrays, functional protein microarrays, and reverse phase protein microarrays. The application segment includes diagnostics, proteomics, and antibody characterization. The end user segment includes hospitals & clinics, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnological companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The prominent players in the market have adopted various strategies for increasing their market share. These include expansion of their geographical presence through collaborations and partnerships and increase in investment in developing long-acting and effective products with lower adverse effects. Major players operating in the protein chip market include Raybiotech Inc, Illumina Inc, Quotient limited, Agilent Technologies, Thermofisher Scientific, Perkin Elmer, Bio-Rad laboratories, Danher Corporation, Merck KGGA, Arrayit Corporation.

North America accounted for the highest share in the protein chip market in 2020, and is expected to dominate during the forecast period. Whereas Asia-Pacific is expected to grow at the highest CAGR.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global mass spectroscopy market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of protein chip used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Technology

  • Analytical Microarrays
  • Functional Protein Microarrays
  • Reverse Phase Protein Microarrays

By Application

  • Diagnostics
  • Proteomics
  • Antibody Characterization

By End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnological Companies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Agilent Technologies Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Perkinelmer Inc.
  • Bio-Rad Laboratories
  • Raybiotech Inc
  • Illumina Inc
  • Quotient Limited
  • Merck KGGA
  • Arrayit Corporation
Frequently Asked Questions about the Global Protein Chip Market

What is the estimated value of the Global Protein Chip Market?

The Global Protein Chip Market was estimated to be valued at $652.8 million in 2020.

What is the growth rate of the Global Protein Chip Market?

The growth rate of the Global Protein Chip Market is 7.7%, with an estimated value of $1367.1 million by 2030.

What is the forecasted size of the Global Protein Chip Market?

The Global Protein Chip Market is estimated to be worth $1367.1 million by 2030.

Who are the key companies in the Global Protein Chip Market?

Key companies in the Global Protein Chip Market include Raybiotech Inc, Illumina Inc, Quotient limited, Agilent Technologies, Thermofisher Scientific, Perkin Elmer, Bio, Rad laboratories and Merck KGGA.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies
  • Arrayit Corporation
  • Bio-Rad laboratories
  • Danher Corporation
  • Illumina Inc
  • Merck KGGA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits to the stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Market Share Analysis, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increasing Prevalence of Cancer
3.5.1.2. Rising Demand of Personalized Diagnosis Technology
3.5.1.3. Emergence in adoption of advanced technology in diagnostics
3.5.2. Restraints
3.5.2.1. Complexity of Production of Protein Chip
3.5.2.2. High Cost of Protein Chip
3.5.3. Opportunities
3.5.3.1. Development of New Protein Chip in Asian Countries
3.6. Impact analysis of COVID-19 on the Protein Chip Market

CHAPTER 4: PROTEIN CHIP MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Analytical Microarrays
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.2.1. Analytical Microarrays by end user
4.2.3. Market share analysis, by country
4.3. Functional Protein Microarrays
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.2.1. Functional Protein Microarrays by end user
4.3.3. Market share analysis, by country
4.4. Reverse Phase Protein Microarray
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.2.1. Reverse Phase Protein Microarrays by end user
4.4.3. Market share analysis, by country

CHAPTER 5: PROTEIN CHIP MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Diagnostics
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis, by country
5.3. Proteomics
5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis, by country
5.4. Antibody Characterization
5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis, by country

CHAPTER 6: PROTEIN CHIP MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital and Clinics
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. Market share analysis, by country
6.3. Diagnostic Laboratories
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. Market share analysis, by country
6.4. Academic and Research institutes
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.4.3. Market share analysis, by country
6.5. Pharmaceutical and Biotechnological Companies
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast
6.5.3. Market share analysis, by country

CHAPTER 7: PROTEIN CHIP MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by technology
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by end user
7.2.6. U.S.
7.2.6.1. Market size and forecast, by technology
7.2.6.2. Market size and forecast, by application
7.2.6.3. Market size and forecast, by end user
7.2.7. Canada
7.2.7.1. Market size and forecast, by technology
7.2.7.2. Market size and forecast, by application
7.2.7.3. Market size and forecast, by end user
7.2.8. Mexico
7.2.8.1. Market size and forecast, by technology
7.2.8.2. Market size and forecast, by application
7.2.8.3. Market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by technology
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by end user
7.3.6. Germany
7.3.6.1. Market size and forecast, by technology
7.3.6.2. Market size and forecast, by application
7.3.6.3. Market size and forecast, by end user
7.3.7. France
7.3.7.1. Market size and forecast, by technology
7.3.7.2. Market size and forecast, by application
7.3.7.3. Market size and forecast, by end user
7.3.8. UK
7.3.8.1. Market size and forecast, by technology
7.3.8.2. Market size and forecast, by application
7.3.8.3. Market size and forecast, by end user
7.3.9. Italy
7.3.9.1. Market size and forecast, by technology
7.3.9.2. Market size and forecast, by application
7.3.9.3. Market size and forecast, by end user
7.3.10. Spain
7.3.10.1. Market size and forecast, by technology
7.3.10.2. Market size and forecast, by application
7.3.10.3. Market size and forecast, by end user
7.3.11. Rest of Europe
7.3.11.1. Market size and forecast, by technology
7.3.11.2. Market size and forecast, by application
7.3.11.3. Market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by technology
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by end user
7.4.6. China
7.4.6.1. Market size and forecast, by technology
7.4.6.2. Market size and forecast, by application
7.4.6.3. Market size and forecast, by end user
7.4.7. Japan
7.4.7.1. Market size and forecast, by technology
7.4.7.2. Market size and forecast, by application
7.4.7.3. Market size and forecast, by end user
7.4.8. India
7.4.8.1. Market size and forecast, by technology
7.4.8.2. Market size and forecast, by application
7.4.8.3. Market size and forecast, by end user
7.4.9. South Korea
7.4.9.1. Market size and forecast, by technology
7.4.9.2. Market size and forecast, by application
7.4.9.3. Market size and forecast, by end user
7.4.10. Australia
7.4.10.1. Market size and forecast, by technology
7.4.10.2. Market size and forecast, by application
7.4.10.3. Market size and forecast, by end user
7.4.11. Rest of Asia-Pacific
7.4.11.1. Market size and forecast, by technology
7.4.11.2. Market size and forecast, by application
7.4.11.3. Market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by technology
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by end user
7.5.6. Brazil
7.5.6.1. Market size and forecast, by technology
7.5.6.2. Market size and forecast, by application
7.5.6.3. Market size and forecast, by end user
7.5.7. Saudi Arabia
7.5.7.1. Market size and forecast, by technology
7.5.7.2. Market size and forecast, by application
7.5.7.3. Market size and forecast, by end user
7.5.8. South Africa
7.5.8.1. Market size and forecast, by technology
7.5.8.2. Market size and forecast, by application
7.5.8.3. Market size and forecast, by end user
7.5.9. Rest of LAMEA
7.5.9.1. Market size and forecast, by technology
7.5.9.2. Market size and forecast, by application
7.5.9.3. Market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES
8.1. Agilent Technologies Inc.
8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Bio-Rad Laboratories, Inc.
8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Product portfolio
8.2.4. Business performance
Source: Corporate Publications and AMR Analysis
8.3. DANAHER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
Source: Corporate Publications and AMR Analysis
8.4. Illumina, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Merck KGAA
8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Product portfolio
8.5.4. Business performance
8.7. Arrayit Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. PerkinElmer Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. QUOTIENT LIMITED
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. RayBiotech Life Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.11. Thermo Fisher Scientific, Inc.
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio6
8.11.5. Business performance
8.11.6. Key strategic moves and developments

List of Tables
TABLE 01. PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 02. PROTEIN CHIP MARKET ANALYTICAL MICROARRAYS, BY REGION, 2020-2030 ($MILLION)
TABLE 03. PROTEIN CHIP MARKET FOR FUNCTIONAL PROTEIN MICROARRAYS SEGMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 04. PROTEIN CHIP MARKET FOR REVERSE PROTEIN MICROARRAY SEGMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 05. PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 06. PROTEIN CHIP MARKET FOR DIAGNOSTICS, BY REGION, 2020-2030 ($MILLION)
TABLE 07. PROTEIN CHIP MARKET FOR PROTEOMICS, BY REGION, 2020-2030 ($MILLION)
TABLE 08. PROTEIN CHIP MARKET FOR ANTIBODY CHARACTERIZATION, BY REGION, 2019-2027 ($MILLION)
TABLE 09. PROTEIN CHIP MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 10. PROTEIN CHIP MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 11. PROTEIN CHIP MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019-2027 ($MILLION)
TABLE 12. PROTEIN CHIP MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
TABLE 13. PROTEIN CHIP MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-20230($MILLION)
TABLE 14. PROTEIN CHIP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA PROTEIN CHIP MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 16. NORTH AMERICA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 18. NORTH AMERICA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 19. U.S. PROTEIN CHIP MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 20. U.S. PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 21. U.S. PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 22. CANADA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 23. CANADA PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 24. CANADA PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 25. MEXICO PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 26. MEXICO PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 27. MEXICO PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28. EUROPE PROTEIN CHIP MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 29. EUROPE PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 30. EUROPE PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 31. EUROPE PROTEIN CHIP MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 32. GERMANY PROTEIN CHIP MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 33. GERMANY PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 34. GERMANY PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35. FRANCE PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 36. FRANCE PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 37. FRANCE PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38. UK PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 39. UK PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 40. UK PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41. ITALY PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 42. ITALY PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 43. ITALY PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44. SPAIN PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 45. SPAIN PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 46. SPAIN PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47. REST OF EUROPE PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 48. REST OF EUROPE PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 49. REST OF EUROPE PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50. ASIA-PACIFIC PROTEIN CHIP MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 51. ASIA-PACIFIC PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC PROTEIN CHIP MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 54. CHINA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 55. CHINA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 56. CHINA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57. JAPAN PROTEIN CHIP MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 58. JAPAN PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 59. JAPAN PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60. INDIA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2019-2027 ($MILLION)
TABLE 61. INDIA PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 62. INDIA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63. SOUTH KOREA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 64. SOUTH KOREA PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 65. SOUTH KOREA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66. AUSTRALIA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 67. AUSTRALIA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 68. AUSTRALIA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC PROTEIN CHIP MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72. LAMEA PROTEIN CHIP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 73. LAMEA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 74. LAMEA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 75. LAMEA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76. BRAZIL PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 77. BRAZIL PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 78. BRAZIL PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79. SAUDI ARABIA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 80. SAUDI ARABIA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 81. SAUDI ARABIA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82. SOUTH AFRICA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 83. SOUTH AFRICA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 84. SOUTH AFRICA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85. REST OF LAMEA PROTEIN CHIP MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 86. REST OF LAMEA PROTEIN CHIP MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 87. REST OF LAMEA PROTEIN CHIP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88. AGILENT: COMPANY SNAPSHOT
TABLE 89. AGILENT: OPERATING SEGMENTS
TABLE 90. AGILENT: PRODUCT PORTFOLIO
TABLE 91. AGILENT: KEY DEVELOPMENTS
TABLE 92. BIO-RAD: COMPANY SNAPSHOT
TABLE 93. BIO-RAD: OPERATING SEGMENTS
TABLE 94. BIO-RAD: PRODUCT PORTFOLIO
TABLE 95. DANAHER: SNAPSHOT
TABLE 96. DANAHER: OPERATING SEGMENTS
TABLE 97. DANAHER: PRODUCT PORTFOLIO
TABLE 98. ILLUMINA: COMPANY SNAPSHOT
TABLE 99. ILLUMINA: OPERATING SEGMENTS
TABLE 100. ILLUMINA: PRODUCT PORTFOLIO
TABLE 101. MERCK: COMPANY SNAPSHOT
TABLE 102. MERCK: OPERATING SEGMENTS
TABLE 103. MERCK: PRODUCT PORTFOLIO
TABLE 104. ARRAYIT: COMPANY SNAPSHOT
TABLE 105. ILLUMINA: OPERATING SEGMENTS
TABLE 106. ARRAYIT: PRODUCT PORTFOLIO
TABLE 107. PERKINELMER: COMPANY SNAPSHOT
TABLE 108. PERKINELMER: OPERATING SEGMENTS
TABLE 109. PERKINELMER: PRODUCT PORTFOLIO
TABLE 110. QUOTIENT LIMITED: COMPANY SNAPSHOT
TABLE 111. QUOTIENT LIMITED: OPERATING SEGMENTS
TABLE 112. QUOTIENT LIMITED: PRODUCT PORTFOLIO
TABLE 113. RAYBIOTECH: COMPANY SNAPSHOT
TABLE 114. RAYBIOTECH: OPERATING SEGMENTS
TABLE 115. RAYBIOTECH: PRODUCT PORTFOLIO
TABLE 116. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 117. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 118. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

List of Figures
FIGURE 01. SEGMENTATION OF PROTEIN CHIP MARKET
FIGURE 02. TOP INVESTMENT POCKETS IN PROTEIN CHIP MARKET
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021*
FIGURE 06. HIGH BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. MODERATE THREAT OF NEW ENTRANTS
FIGURE 09. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS, 2020
FIGURE 12. RESTRAINTS AND DRIVERS: PROTEIN CHIP MARKET
FIGURE 13. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR ANALYTICAL MICROARRAYS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR FUNCTIONAL PROTEIN MICROARRAYS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR REVERSE PROTEIN MICROARRAY SEGMENT, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR PROTEOMICS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR ANTIBODY CHARACTERIZATION, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF PROTEIN CHIP MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 (%)
FIGURE 23. AGILENT: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. AGILENT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25. AGILENT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26. BIO-RAD: NET SALES, 2018-2020 ($MILLION)
FIGURE 27. BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28. BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29. DANAHER: NET SALES, 2018-2020 ($MILLION)
FIGURE 30. DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31. DANAHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32. ILLUMINA: NET SALES, 2018-2020 ($MILLION)
FIGURE 33. ILLUMINA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34. ILLUMINA: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 35. MERCK: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37. MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. PERKINELMER: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. PERKINELMER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. PERKINELMER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. QUOTIENT LIMITED: NET SALES, 2018-2020 ($MILLION)
FIGURE 43. QUOTIENT LIMITED: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44. THERMO FISHER SCIENTIFIC: REVENUE, 2018-2020 ($MILLION)
FIGURE 45. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
Note: Product cover images may vary from those shown
  • Raybiotech Inc
  • Illumina Inc
  • Quotient limited
  • Agilent Technologies
  • Thermofisher Scientific
  • Perkin Elmer
  • Bio-Rad laboratories
  • Danher Corporation
  • Merck KGGA
  • Arrayit Corporation
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...